NEXGEL to Present at the iAccess Alpha Best Ideas Spring Virtual Conference on March 12th
LANGHORNE, Pa., March 04, 2024 (GLOBE NEWSWIRE) — NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of […]
Bitdeer Pre-Announces Financial and Operating Results for the Fourth Quarter of 2023
SINGAPORE, March 04, 2024 (GLOBE NEWSWIRE) — Bitdeer Technologies Group (NASDAQ: BTDR) (“Bitdeer” or the “Company”), a world-leading technology company […]
Vaxcyte Completes Enrollment of Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease (IPD) in Infants
— Company Expects to Announce Topline Safety, Tolerability and Immunogenicity Data from Primary Immunization Series by the End of the […]
Brilliant Earth to Report Fourth Quarter and Full Year 2023 Financial Results on March 14th
SAN FRANCISCO, Calif., March 04, 2024 (GLOBE NEWSWIRE) — Brilliant Earth Group, Inc. (“Brilliant Earth” or the “Company”) (NASDAQ: BRLT), […]
HeartCore Announces the Sale of Go IPO Warrant for $9 Million
NEW YORK and TOKYO, March 04, 2024 (GLOBE NEWSWIRE) — HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), a […]
Phunware Sets Fourth Quarter and Full Year 2023 Earnings Call for Tuesday, March 12, 2024 at 4:30 PM ET
AUSTIN, Texas, March 04, 2024 (GLOBE NEWSWIRE) — Phunware, Inc. (NASDAQ: PHUN) (“Phunware” or “the Company”), the leading provider of […]
Alarum to Participate in the 36th Annual Roth Conference
Tel Aviv, Israel, March 04, 2024 (GLOBE NEWSWIRE) — Alarum Technologies Ltd. (Nasdaq, TASE: ALAR) (“Alarum” or the “Company”), a […]
Mobiquity Technologies Expands Partnership with AWINR Brands, Adding Twelve New Clients to its Digital Marketing Platform
NEW YORK, March 04, 2024 (GLOBE NEWSWIRE) — Mobiquity Technologies, Inc. (OTC: MOBQ) (the “Company”), a leading provider of next-generation […]
GRI Bio Receives MHRA Authorization to Conduct Phase 2a Biomarker Study Evaluating GRI-0621 in the United Kingdom
MHRA authorization expands ongoing U.S. Phase 2a biomarker study evaluating lead program GRI-0621 for the treatment of Idiopathic Pulmonary Fibrosis […]
HII Completes Acceptance Trials on Richard M. McCool Jr. (LPD 29)
PASCAGOULA, Miss., March 04, 2024 (GLOBE NEWSWIRE) — HII’s (NYSE: HII) Ingalls Shipbuilding division announced today the successful completion of […]
